Medetomidine is an animal tranquilliser with more sudden and dangerous withdrawal effects than other sedatives ...
Newron Pharmaceuticals S.p.A. ("Newron") (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral ...
NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI), a clinical-stage biopharmaceutical company developing brain-penetrant therapeutics for central nervous system (CNS) cancers, today announced newly ...
Ms. Ishak brings more than 25 years of corporate legal and strategic leadership experience in the life sciences industry ...
New ideas can shift everything you thought you understood, and these science books offer that rare spark that leaves your ...
India’s digital revolution has exposed millions to a criminal dystopia. This is the story of a neurologist placed under ...
Merck , known as MSD outside the United States and Canada, announced today that the province of Saskatchewan has added CAPVAXIVE®, a 21-valent pneumococcal conjugate vaccine, to its publicly funded ...
What if, instead of beating yourself up for this urge to hibernate during winter, you embraced it and made the most of it?
It means muscles can be tight, sometimes spastic, always weak. But the signs aren’t usually visible in the early ...
When I returned to running this year, I didn’t realize my rekindled relationship with the sport coincided with a 2025 running ...
Coherus Oncology, Inc. (NASDAQ: CHRS) today announced compelling six-year overall survival (OS) follow-up results from the Phase 3 JUPITER-02 trial evaluating LOQTORZI® (toripalimab-tpzi) plus ...
Even when your body is capable of high performance, interference, stress, and misalignment create an internal traffic jam.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results